Company · CIK 0001641281 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Bolt Biotherapeutics, Inc. · BOLT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 SForm 4 → | Sep 21, 6:05 pm EDT | Grant YonehiroChief Operating Officer | 13,176 | $3.32 | $43,807 | 17,269 | −43.3% | late |
| Sep 16, 2026 SForm 4 → | Sep 21, 6:04 pm EDT | Sarah NemecSenior VP, Finance and PAO | 7,842 | $3.32 | $26,072 | 17,082 | −31.5% | late |
| Sep 16, 2026 SForm 4 → | Sep 21, 6:03 pm EDT | William P. QuinnPresident, CEO and CFO, Director | 17,566 | $3.32 | $58,402 | 25,384 | −40.9% | late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.